Private company

TANG CAPITAL MANAGEMENT LLC

Limited liability company registered in the United States, active since 2012. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersSan Diego, United States²
Legal formLimited Liability Company²
LEI254900I2WXG9CW1LL265²
StatusActive²
LEI statusIssued and current²
Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States²
Registered withDivision of Corporations, Department of State, 5261983²

See how the biggest companies compare on our leaderboards

Corporate structure

TANG CAPITAL MANAGEMENT LLC sits at the top of its group. 52 entities, 6 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

TANG CAPITAL MANAGEMENT LLC San Diego, California, United States
- ACELYRIN, Inc. Stake · Agoura Hills, California
- Adicet Bio, Inc. Stake · Boston, Massachusetts
- Aeglea BioTherapeutics Stake · Austin
- Allakos Inc. Stake · San Carlos, California, United States
- Altimmune, Inc. Stake · Gaithersburg, Maryland, United States
- ALX ONCOLOGY HOLDINGS INC Stake · South San Francisco, California
- ANAPTYSBIO, INC Stake · San Diego, California, United States
- ASLAN Pharmaceuticals Ltd Stake · Singapore, Singapore
- Atea Pharmaceuticals, Inc. Stake · Boston, Massachusetts
- Aurinia Pharmaceuticals Inc. Stake · Edmonton, Canada
- BioAtla Stake · San Diego
- Bolt Biotherapeutics, Inc. Stake · Redwood City, California, United States
- Boundless Bio (United States) Stake · La Jolla, California
- CAPRICOR THERAPEUTICS, INC. Stake · Beverly Hills, California, United States
- CARGO Therapeutics, Inc. Stake · San Carlos, California
- Compass Therapeutics, Inc. Stake · Boston, Massachusetts
- Corbus Pharmaceuticals Stake · Norwood, Massachusetts, United States
- CRESCENT BIOPHARMA, INC. Stake · Waltham, Massachusetts
- CytomX Therapeutics, Inc. Stake · South San Francisco, California, United States
- Elevation Oncology, Inc. Stake · Boston, Massachusetts
- Essa Pharma (United States) Stake · Houston
- Evolus, Inc. Stake · Newport Beach, California, United States
- Fulcrum Therapeutics (United States) Stake · Cambridge, Massachusetts
- Galápagos NV Stake · Mechelen, Belgium
- Helus Pharma Inc. Stake · A1
- and 26 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (51 companies). Each entity in the chart links to its source.

Timeline

Dec 19, 2012Founded TANG CAPITAL MANAGEMENT LLC is founded²

Filings

23 filings to the SEC since October 2021: 23 other. The latest 20:

Aug 31, 2026N-PX EDGAR
Aug 14, 202613F-HR EDGAR
May 15, 202613F-HR EDGAR
Feb 17, 202613F-HR EDGAR
Nov 14, 202513F-HR EDGAR
Sep 2, 2025N-PX EDGAR
Aug 14, 202513F-HR EDGAR
May 15, 202513F-HR EDGAR
Feb 14, 202513F-HR EDGAR
Nov 14, 202413F-HR EDGAR
Aug 30, 2024N-PX EDGAR
Aug 14, 202413F-HR EDGAR
May 15, 202413F-HR EDGAR
Feb 14, 202413F-HR EDGAR
Nov 14, 202313F-HR EDGAR
Aug 14, 202313F-HR EDGAR
May 15, 202313F-HR EDGAR
Feb 14, 202313F-HR EDGAR
Nov 14, 202213F-HR EDGAR
Aug 15, 202213F-HR EDGAR

The 23 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

TANG CAPITAL MANAGEMENT LLC has told the SEC it owns more than 5% of 51 companies, latest first (Schedules 13D and 13G).

Skye Bioscience, Inc.SCHEDULE 13G Oct 14, 2026³
Atea Pharmaceuticals, Inc.SCHEDULE 13G Oct 6, 2026⁴
Nano Dimension Ltd.SCHEDULE 13G Jun 30, 2026 to Aug 21, 2026⁵
CAPRICOR THERAPEUTICS, INC.SCHEDULE 13G/A Jan 26, 2026 to Aug 14, 2026⁶
KalVista Pharmaceuticals, Inc.SCHEDULE 13G/A Nov 14, 2024 to Aug 14, 2026⁷
Fulcrum Therapeutics (United States)SCHEDULE 13G/A Jun 10, 2026 to Jul 15, 2026⁸
Boundless Bio (United States)SCHEDULE 13G Jun 29, 2026⁹
Aurinia Pharmaceuticals Inc.SCHEDULE 13D/A Sep 12, 2024 to Jun 4, 2026¹⁰
Altimmune, Inc.SCHEDULE 13G/A May 15, 2026¹¹
CRESCENT BIOPHARMA, INC.SCHEDULE 13G/A Oct 9, 2025 to May 15, 2026¹²
Ventyx Biosciences, Inc.SCHEDULE 13G/A May 15, 2026¹³
Kezar Life Sciences, Inc.SCHEDULE 13D/A Oct 8, 2024 to May 13, 2026¹⁴
PureTech VenturesSCHEDULE 13G Apr 29, 2026¹⁵
Adicet Bio, Inc.SCHEDULE 13G/A Nov 14, 2024 to Feb 17, 2026¹⁶
Aeglea BioTherapeuticsSCHEDULE 13G/A May 1, 2025 to Feb 17, 2026¹⁷
CytomX Therapeutics, Inc.SCHEDULE 13G/A Nov 14, 2024 to Feb 17, 2026¹⁸
Evolus, Inc.SCHEDULE 13G/A Nov 14, 2024 to Feb 17, 2026¹⁹
Helus Pharma Inc.SCHEDULE 13G/A Dec 3, 2024 to Feb 17, 2026²⁰
Keros Therapeutics, Inc.SCHEDULE 13G/A Oct 22, 2025 to Feb 17, 2026²¹
Nkarta Therapeutics (United States)SCHEDULE 13G/A Jan 27, 2025 to Feb 17, 2026²²
Precision BioSciencesSCHEDULE 13G/A Nov 14, 2024 to Feb 17, 2026²³
Tarsus Pharmaceuticals, Inc.SCHEDULE 13G/A May 15, 2025 to Feb 17, 2026²⁴
ALX ONCOLOGY HOLDINGS INCSCHEDULE 13G/A May 15, 2025 to Nov 14, 2025²⁵
Bolt Biotherapeutics, Inc.SCHEDULE 13G/A May 15, 2025 to Nov 14, 2025²⁶
Compass Therapeutics, Inc.SCHEDULE 13G/A Jan 16, 2025 to Nov 14, 2025²⁷
Essa Pharma (United States)SCHEDULE 13G/A Nov 8, 2024 to Nov 14, 2025²⁸
Galápagos NVSCHEDULE 13G Feb 14, 2025 to Oct 29, 2025²⁹
ImmunocoreSCHEDULE 13G Oct 24, 2025³⁰
PMV Pharmaceuticals, Inc.SCHEDULE 13G Sep 23, 2025³¹
HilleVax, Inc.SCHEDULE 13D/A May 2, 2025 to Sep 19, 2025³²

All 51 companies

iTeos Therapeutics, Inc.SCHEDULE 13D/A Sep 30, 2024 to Sep 3, 2025³³
CARGO Therapeutics, Inc.SCHEDULE 13D/A Feb 21, 2025 to Aug 21, 2025³⁴
Elevation Oncology, Inc.SCHEDULE 13G/A May 15, 2025 to Aug 14, 2025³⁵
Outlook Therapeutics, Inc.SCHEDULE 13G/A May 15, 2025 to Aug 14, 2025³⁶
REVIVA PHARMACEUTICALS HOLDINGS, INC.SCHEDULE 13G/A May 15, 2025 to Aug 14, 2025³⁷
ACELYRIN, Inc.SCHEDULE 13D/A Feb 20, 2025 to May 23, 2025³⁸
Allakos Inc.SCHEDULE 13D/A Feb 3, 2025 to May 19, 2025³⁹
Journey Medical CorpSCHEDULE 13G/A Nov 29, 2024 to May 15, 2025⁴⁰
Kiniksa Pharmaceuticals International, plcSCHEDULE 13G Apr 4, 2025⁴¹
Pliant (United States)SCHEDULE 13D Mar 10, 2025⁴²
Monopar TherapeuticsSCHEDULE 13G/A Oct 24, 2024 to Feb 14, 2025⁴³
ANAPTYSBIO, INCSC 13G/A Nov 14, 2024⁴⁴
BioAtlaSC 13G/A Nov 14, 2024⁴⁵
Corbus PharmaceuticalsSC 13G/A Nov 14, 2024⁴⁶
IRulya Therapeutics Inc.SC 13G/A Nov 14, 2024⁴⁷
LENZ Therapeutics, Inc.SC 13G/A Nov 14, 2024⁴⁸
LianBioSC 13G Nov 14, 2024⁴⁹
OnKure Therapeutics, Inc.SC 13G/A Nov 14, 2024⁵⁰
Singular Genomics Systems, Inc.SC 13D Sep 18, 2024⁵¹
ASLAN Pharmaceuticals LtdSC 13G Apr 21, 2022⁵²
Inspirato IncSC 13G Apr 21, 2022⁵³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTANG CAPITAL MANAGEMENT LLC filings on SEC EDGAR
2
GLEIFTANG CAPITAL MANAGEMENT LLC LEI record (254900I2WXG9CW1LL265)
3
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G on Skye Bioscience, Inc.
4
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G on Atea Pharmaceuticals, Inc.
5
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G on Nano Dimension Ltd.
6
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on CAPRICOR THERAPEUTICS, INC.
7
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on KalVista Pharmaceuticals, Inc.
8
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Fulcrum Therapeutics (United States)
9
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G on Boundless Bio (United States)
10
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13D/A on Aurinia Pharmaceuticals Inc.
11
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Altimmune, Inc.
12
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on CRESCENT BIOPHARMA, INC.
13
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Ventyx Biosciences, Inc.
14
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13D/A on Kezar Life Sciences, Inc.
15
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G on PureTech Ventures
16
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Adicet Bio, Inc.
17
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Aeglea BioTherapeutics
18
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on CytomX Therapeutics, Inc.
19
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Evolus, Inc.
20
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Helus Pharma Inc.
21
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Keros Therapeutics, Inc.
22
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Nkarta Therapeutics (United States)
23
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Precision BioSciences
24
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Tarsus Pharmaceuticals, Inc.
25
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on ALX ONCOLOGY HOLDINGS INC
26
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Bolt Biotherapeutics, Inc.
27
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Compass Therapeutics, Inc.
28
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Essa Pharma (United States)
29
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G on Galápagos NV
30
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G on Immunocore
31
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G on PMV Pharmaceuticals, Inc.
32
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13D/A on HilleVax, Inc.
33
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13D/A on iTeos Therapeutics, Inc.
34
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13D/A on CARGO Therapeutics, Inc.
35
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Elevation Oncology, Inc.
36
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Outlook Therapeutics, Inc.
37
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on REVIVA PHARMACEUTICALS HOLDINGS, INC.
38
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13D/A on ACELYRIN, Inc.
39
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13D/A on Allakos Inc.
40
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Journey Medical Corp
41
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G on Kiniksa Pharmaceuticals International, plc
42
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13D on Pliant (United States)
43
SEC EDGARTANG CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Monopar Therapeutics
44
SEC EDGARTANG CAPITAL MANAGEMENT LLC SC 13G/A on ANAPTYSBIO, INC
45
SEC EDGARTANG CAPITAL MANAGEMENT LLC SC 13G/A on BioAtla
46
SEC EDGARTANG CAPITAL MANAGEMENT LLC SC 13G/A on Corbus Pharmaceuticals
47
SEC EDGARTANG CAPITAL MANAGEMENT LLC SC 13G/A on IRulya Therapeutics Inc.
48
SEC EDGARTANG CAPITAL MANAGEMENT LLC SC 13G/A on LENZ Therapeutics, Inc.
49
SEC EDGARTANG CAPITAL MANAGEMENT LLC SC 13G on LianBio
50
SEC EDGARTANG CAPITAL MANAGEMENT LLC SC 13G/A on OnKure Therapeutics, Inc.
51
SEC EDGARTANG CAPITAL MANAGEMENT LLC SC 13D on Singular Genomics Systems, Inc.
52
SEC EDGARTANG CAPITAL MANAGEMENT LLC SC 13G on ASLAN Pharmaceuticals Ltd
53
SEC EDGARTANG CAPITAL MANAGEMENT LLC SC 13G on Inspirato Inc